CEA [CHINA EASTERN AIRLINES] 6-K: (Original Filing)
[]
LITB [LightInTheBox] 6-K: (Original Filing)
[LightInTheBox Holding Co., Ltd. Responds to Class Action Lawsuit The Company has reviewed the claims asserted in the complaint and believes that they are without merit. While the Company has not yet been served with a copy of the complaint, it intends to work with Simpson Thacher & Bartlett LLP, its legal counsel, to vigorously defend itself in this matter.]
LITB [LightInTheBox] 6-K: LightInTheBox Holding Co., Ltd. Responds to Class Action
[LightInTheBox Holding Co., Ltd. Responds to Class Action Lawsuit The Company has reviewed the claims asserted in the complaint and believes that they are without merit. While the Company has not yet been served with a copy of the complaint, it intends to work with Simpson Thacher & Bartlett LLP, its legal counsel, to vigorously defend itself in this matter.]
BSPM [Biostar Pharmaceuticals,] S-8: (Original Filing)
[FORM S-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT UNDER THE Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 including zip code) (Full title of the plan) Ronghua Wang, President and Chief Executive Officer No. 588 Shiji Xi Avenue,] [Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan This Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee] [[Schiff Hardin letterhead] August 28, 2013 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China Ladies and Gentlemen: Schiff Hardin LLP EX-5.1 3 ex5-1.htm] [Consent of Independent Registered Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated August 28, 2013 of Biostar Pharmaceuticals, Inc. of our report dated April 11, 2013 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Certified Public Accountants Hong Kong August 28, 2013 EX-23.2 5 ex23-2.htm]
BSPM [Biostar Pharmaceuticals,] S-8: FORM S-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT
[FORM S-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT UNDER THE Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 including zip code) (Full title of the plan) Ronghua Wang, President and Chief Executive Officer No. 588 Shiji Xi Avenue,] [Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan This Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee] [[Schiff Hardin letterhead] August 28, 2013 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China Ladies and Gentlemen: Schiff Hardin LLP EX-5.1 3 ex5-1.htm] [Consent of Independent Registered Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated August 28, 2013 of Biostar Pharmaceuticals, Inc. of our report dated April 11, 2013 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Certified Public Accountants Hong Kong August 28, 2013 EX-23.2 5 ex23-2.htm]
CEA [CHINA EASTERN AIRLINESRP] 6-K: China Eastern Airlinesrporation Limitedte August 28, 2013 ByT=””>
[China Eastern Airlinesrporation Limitedte August 28, 2013 ByT=""> (a joint stock limitedmpanyorporated in the Peoples Republic of China with limited liability) (Stockde: 00670) RESOLUTIONS PASSED AT THE SECOND ORDINARY MEETING OF THE SEVENTH SESSION OF THE BOARD OF DIRECTORS Articlesmpany Meeting Board Directors Mr. Liu Shaoyong, our Chairman; Mr. Ma Xulun, our Vice Chairman; Mr.]
CHOP [China Gerui Advanced Materials] 6-K: China Gerui Advanced Materials Group Limited ZHENGZHOU, China
[China Gerui Advanced Materials Group Limited ZHENGZHOU, China Mr. Mingwang Lu, Chairman and Chief Executive Officer of China Gerui, commented, “Second quarter results reflected the continuing weakness in demand for steel in China and the pricing pressure resulting from the over-capacity of steel production in China. Our average selling price declined by 15.7% year-over-year in the 2013 second quarter, which] []
PTR [PETROCHINA CO] 6-K: (Original Filing)
[PETROCHINA COMPANY LIMITED (a joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock Code: 857) ANNOUNCEMENT Board Company Mr Li Hualin, the former Secretary to the Board of Directors (the By order of the Board PetroChina Company Limited Chairman Zhou Jiping Beijing, the PRC 28 August 2013 As at the date of this] [99.1 Announcement dated August 28, 2013 in connection with the corporate secretary of the Company. PetroChina Company Limited Dated: August 28, 2013]
LITB [LightInTheBox] 6-K: (Original Filing)
[LightInTheBox Responds to Class Action Lawsuit Thempany has reviewed the claimsserted in themplaint and believes that they are without merit. While thempany has not yet been served with apy of themplaint, it intends to work with Simpson Thacher & Bartlett its legalunsel, to vigorously defend itself in this matter.]
CMGE [China Mobile Games & Entertainment] 6-K: (Original Filing)
[CMGE Reports Second Quarter 2013 Unaudited Financial Results HONG KONG, August 28, 2013 China Mobile Games and Entertainment Group Limited (CMGE or the Company) (Nasdaq: CMGE), a leading mobile game company in China, today reported its unaudited financial results for the second quarter ended Second Quarter 2013 Financial Highlights Revenues were RMB72.0 million (US$11.7 million 1 ), 18.6%] [China Mobile Games and Entertainment Group Limited Description]
